21 March 2014
: Case report
Novel Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE) Syndrome due to Insulin Therapy
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Unexpected drug reaction
Naba Raj MainaliABEF, Torrey R. SchmidtAEF, Richard AlweisAEF, David L. GeorgeAEFDOI: 10.12659/AJCR.890318
Am J Case Rep 2014; 15:119-122
Abstract
Abstract
Background: Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome is a rare clinical entity characterized by the sudden onset of inflammatory arthritis and marked pitting edema on upper and lower extremities. RS3PE is considered a rheumatic process distinct from rheumatoid arthritis, which may occasionally represent a paraneoplastic syndrome.
Case Report: Herein, we describe a rare case of RS3PE associated with insulin therapy in a patient with no evidence of underlying malignancy.
Conclusions: To the best of our knowledge, this is the first case report of RS3PE associated with insulin therapy. Physicians should look at the introduction of drugs as possible triggers for the development of RS3PE.
Keywords: steroid, RS3PE, synovitis, Insulin - therapeutic use, hydroxychloroquine
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946435
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947160
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947567
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948238
Most Viewed Current Articles
21 Jun 2024 : Case report
100,489
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
53,790
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
36,376
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
25,034
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200